Dr. Volpp is the founding Director of the Leonard Davis Institute Center for Health Incentives and Behavioral Economics, one of two NIH-funded Centers on Behavioral Economics and Health in the United States. He is also a Professor of Medicine and Vice Chairman for Health Policy of the Department of Medical Ethics and Policy at the Perelman School of Medicine, a Professor of Health Care Management at the Wharton School, and one of two Directors of the University of Pennsylvania CDC Prevention Research Center. Dr. Volpp’s research on the impact of financial and organizational incentives on health behavior and health outcomes work has been recognized by numerous awards including the Alice S. Hersh Award from AcademyHealth; the British Medical Journal Group Award for translating Research into Practice; the outstanding paper of the year from multiple research societies; a Presidential Early Career Award for Scientists and Engineers (PECASE); the Association for Clinical and Translational Science Distinguished Investigator Award for Career Achievement and Contributions to Clinical and Translational Science; and the Matilda White Riley Award for outstanding contributions to social and behavioral science research from NIH. He served as a member of the editorial board of the Annals of Internal Medicine and is now a Contributing Writer to JAMA. He is an elected member of several honorary societies including the Institute of Medicine (IOM) of the National Academy of Sciences, the American Society of Clinical Investigation (ASCI), and the Association of American Physicians (AAP). Volpp did his medical training at the University of Pennsylvania and Brigham and Women’s Hospital and his training in Economics at the Wharton School. He is a board-certified general internist and practicing physician at the Philadelphia VA Medical Center. He has collaborated with and advised a wide variety of private and public sector entities in the United States and internationally and his work has been covered by major media outlets throughout the world such as the New York Times, The Wall Street Journal, Good Morning America, The Economist, the BBC, Der Spiegel, and the Australian National Radio.
NEJM Catalyst Insights Council members say patient engagement technology tools must be patient-centric and are most useful for managing chronic disease.
Behavioral interventions can have very different effects in different portions of the population.
The U.S. has pockets of innovation, but they’re not as widespread as in other countries.
Results of the second NEJM Catalyst survey on patient engagement show early success, but most initiatives have yet to be scaled up.
Can we expect patients to understand the subtleties of value-based benefits design when it’s hard enough for the experts?
Patient Engagement Report: Improved Engagement Leads to Better Outcomes, but Better Tools Are Needed
Data from the NEJM Catalyst Insights Council opinion leaders show that they have strong views on which interventions work and which do not, but low rates of engagement appear to be the norm.
Clinicians might not have time in their encounters with patients, but they can act as the bridge to those who can.
It’s about adding friction to unhealthy choices while removing friction from healthy ones.
How paternalistic should providers be with patients when trying to improve their health behavior?